Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: Pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials.
Hideo-Kajita A, Garcia-Garcia HM, Kolm P, Azizi V, Ozaki Y, Dan K, Ince H, Kische S, Abizaid A, Töelg R, Lemos PA, Van Mieghem NM, Verheye S, von Birgelen C, Christiansen EH, Wijns W, Lefèvre T, Windecker S, Waksman R, Haude M; BIOFLOW-II, BIOSOLVE-II and BIOSOLVE-III investigators.
Hideo-Kajita A, et al. Among authors: haude m.
Int J Cardiol. 2020 Feb 1;300:60-65. doi: 10.1016/j.ijcard.2019.11.003. Epub 2019 Nov 6.
Int J Cardiol. 2020.
PMID: 31718825
Clinical Trial.